Abstract
Background: Magnesium depletion and hypomagnesemia are common among furosemide‐treated patients with chronic congestive heart failure.
Hypothesis: This investigation evaluated clinical and metabolic effects of oral magnesium supplementation.
Methods: Ten patients with severe congestive heart failure maintained on high dose furosemide (≥ 80 mg/day) received a supplement of oral magnesium citrate 300 mg/daily for 30 days. Clinical parameters were followed, and peripheral blood mononuclear cell magnesium and zinc content, serum and urine magnesium, potassium, zinc, calcium, phosphorus, and creatinine were assessed.
Results: Peripheral blood mononuclear cell magnesium content and serum potassium rose significantly at the end of the study (2.09 ± 1.89 to 3.99 ± 2.26 m̈g/mg cell protein, p< 0.05, and 4.17 ± 0.38 to 4.39 ± 0.27 mEq/l, p <0.05, respectively), while the other parameters remained unchanged.
Conclusion: In some of these patients, oral magnesium supplementation is effective in achieving substantial increments in intracellular magnesium and serum potassium which, in turn, may have cardioprotective effects.
Keywords: peripheral blood mononuclear cell magnesium, peripheral blood mononuclear cell zinc, serum magnesium, zinc, calcium, potassium, magnesium citrate, congestive heart failure
Full Text
The Full Text of this article is available as a PDF (445.1 KB).
Reference
- 1. Wester PO: Electrolyte balance in heart failure and the role for magnesium ions. Am J Cardiol 1992; 70: 44c–49c [DOI] [PubMed] [Google Scholar]
- 2. AL‐Ghamdi SMG, Cameron EC, Sutton RAL: Magnesium deficiency: Pathophysiologic and clinical overview. Am J Kidney Dis 1994; 24: 737–752 [DOI] [PubMed] [Google Scholar]
- 3. Leier CV, Dei Cas L, Metra M: Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia and hypomagnesemia. Am Heart J 1994; 128: 564–574 [DOI] [PubMed] [Google Scholar]
- 4. Ryan MP, Ryan MF, Counihan TB: The effect of diuretics on lymphocyte magnesium and potassium. Acta Med Scand 1981; 647 (suppl): 153–161 [DOI] [PubMed] [Google Scholar]
- 5. Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ: Effects of long‐term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993; 72: 1156–1162 [DOI] [PubMed] [Google Scholar]
- 6. Gottlieb SS: Importance of magnesium in congestive heart failure. Am J Cardiol 1989; 63: 39G–42G [DOI] [PubMed] [Google Scholar]
- 7. Eichhorn EJ, Tandon PK, DiBianco R, Timmis GC, Fenster PE, Shannon J, Packer M: Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: The PROMISE study. J Am Coll Cardiol 1993; 21: 634–640 [DOI] [PubMed] [Google Scholar]
- 8. Dorup I, Skajaa K, Thybo NK: Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium‐potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Int Med 1993; 233: 117–123 [DOI] [PubMed] [Google Scholar]
- 9. Davies DL, Fraser R: Do diuretics cause magnesium deficiency? Br J Clin Pharmacol 1993; 36: 1–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Wester PO, Dyckner T: Intracellular electrolytes in cardiac failure. Acta Med Scand 1986; 707 (suppl): 33–36 [DOI] [PubMed] [Google Scholar]
- 11. Boyum A: Isolation of mononuclears and granulocytes from human blood. J Clin Lab Inves 1964; 21 (suppl 97): 77–89 [PubMed] [Google Scholar]
- 12. Bradford M: A rapid and sensitive method for the quantitation of microgram quantitive of protein utilizing the principle of protein dye binding. Ann Biochem 1976; 72: 248–254 [DOI] [PubMed] [Google Scholar]
- 13. Ralston MA, Murnane MR, Kelley RE, Altschuld RA, Unverferth DV, Leier CV: Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 1989; 80: 573–580 [DOI] [PubMed] [Google Scholar]
- 14. Kafka H, Langevin L, Armstrong PW: Serum magnesium and potassium in acute myocardial infarction influence on ventricular arrhythmias. Arch Intern Med 1987; 147: 465–469 [PubMed] [Google Scholar]
- 15. Dorup I, Skajaa K, Kjeldsen K, Clausen T: Reduced concentrations of potassium, magnesium and sodium—potassium pumps in human skeletal muscle during treatment with diuretics. Br Med J 1988; 296: 455–458 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Lim P, Jacob E: Magnesium deficiency in patients on long‐term diuretic therapy for heart failure. Br Med J 1972; 3: 620–622 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Urdal P, Landmark K: Measurement of magnesium in mononuclear blood cells. Clin Chem 1989; 35: 1559–1560 [PubMed] [Google Scholar]
- 18. Geven WB, Vogels‐Mentink GM, Willems JL, de Boo T, Lemmens W, Monnens LAH: Reference value of magnesium and potassium in mononuclear cells and erythrocytes of children. Clin Chem 1990; 36/7: 1323–1327 [PubMed] [Google Scholar]
- 19. Costello RB, Moser‐Veillon PB, DiBianco R: Magnesium supplementation in patients with congestive heart failure. J Am Coll Nutr 1997; 16: 22–31 [DOI] [PubMed] [Google Scholar]
- 20. Dyckner T, Wester P‐O, Widman L: Effects of peroral magnesium on plasma and skeletal muscle electrolytes in patients on long‐term diuretic therapy. Int J Cardiol 1988; 19: 81–87 [DOI] [PubMed] [Google Scholar]
- 21. Gottlieb SS, Fisher ML, Krichten C, Patten RD, Pressel M, Brackett J: Is oral magnesium replacement antiarrhythmic in patients with congestive heart failure? (abstr). J Am Coll Cardiol 1993; 21: 366 [Google Scholar]